This article is more than 5 years old. Information may no longer be current.

Imprimis reports $19 million net loss in 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Imprimis Pharmaceuticals reported a net loss of $19 million, or $1.50 per common share, in 2016 compared with a net loss of $15.9 million, or $1.66 per common share, in 2015, according to a company press release.

Total revenue for the year was up 105% from 2015 to $19.9 million, and ophthalmology-related sales were up 200% to $11 million.

In the fourth quarter, the company reported a net loss of $6.1 million compared with a net loss of $5.1 million in the same period of 2015.

Revenue in the fourth quarter was $5.8 million, an increase of 65% from 2015’s fourth quarter revenue of $3.5 million.